Have a feature idea you'd love to see implemented? Let us know!
Back to UTHR overview

UTHR UNITED THERAPEUTICS PE ratio, current and historical analysis

As at Dec 20, 2024, the UTHR stock has a PE ratio of 14.79. This is based on the current EPS of $24.31 and the stock price of $359.58 per share. An increase of 20% has been seen in the P/E ratio compared to the average of 12.3 of the last 4 quarters.

UTHR PE ratio history

How has UTHR's PE ratio performed in the past

The mean historical PE ratio of UNITED THERAPEUTICS over the last ten years is 13.97. The current 14.79 PE ratio is 6% above the historical average. Over the past ten years, UTHR's PE ratio was at its highest in the Jun 2015 quarter at 47.14, with a price of $173.95 and an EPS of $3.69. The Jun 2016 quarter recorded the bottom point at 4.74, with a price of $105.92 and an EPS of $22.35.

Average
13.97
Median
11.74
Minimum
4.74
Maximum
47.14

UNITED THERAPEUTICS PE ratio by year

Maximum annual increase: 76.93% in 2017

Maximum annual decrease: -48.36% in 2018

Year PE ratio Change
2023 10.45 -39.94%
2022 17.4 -14.62%
2021 20.38 56.41%
2020 13.03 N/A
2019 N/A N/A
2018 8.04 -48.36%
2017 15.57 76.93%
2016 8.8 -20.36%
2015 11.05 -39.75%
2014 18.34 -43.4%

UTHR average PE ratio chart

What is the average PE ratio of UTHR for the past years

Currently, UTHR's PE ratio is greater than its 3, 5 and 10-year historical averages.

3-year avg
13.89
5-year avg
13.82
10-year avg
13.97
15-year avg
20.18

UTHR PE vs peers

What is UTHR's PE ratio compared to its peers

UTHR's PE ratio is lower than its peer stocks LLY and PFE.

Stock name PE ratio Market cap
UTHR UNITED THERAPEUTICS Corp 14.79 $16.05B
CAH Cardinal Health Inc 22.83 $28.63B
PFE Pfizer Inc 34.68 $149.38B
LLY ELI LILLY & Co 82.64 $728.85B
BAX Baxter International Inc 140.48 $15.06B
GILD Gilead Sciences Inc 925.7 $115.37B
TEVA Teva Pharmaceutical Industries Ltd N/A $25.03B
CYTK Cytokinetics Inc N/A $5.77B

Frequently asked questions

What is UNITED THERAPEUTICS's PE ratio?

As of Dec 20, 2024, UTHR stock has a price to earnings ratio of 14.79.

What is the 3-year average PE ratio for UNITED THERAPEUTICS (UTHR)?

The 3-year average PE ratio for UTHR stock is 13.89.

What is the 5-year average PE ratio for UNITED THERAPEUTICS (UTHR)?

The 5-year average PE ratio for UTHR stock is 13.82.

What is the highest PE ratio for UTHR?

Over the last ten years, the quarterly PE ratio reached a historic high of 47.14 in the Jun 2015 quarter.

How does the current PE ratio for UTHR compare to its historical average?

UTHR's current price to earnings ratio is 6% above its 10-year historical average.

How is UTHR's PE ratio calculated (UNITED THERAPEUTICS PE ratio formula)?

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Dec 20, 2024), UNITED THERAPEUTICS's stock price is $359.58. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $24.31. Therefore, UNITED THERAPEUTICS's P/E ratio for today is 14.79. PE RATIO(14.79) = STOCK PRICE($359.58) / TTM EPS($24.31)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.